Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

New indication claimed for EPO

Sep. 20, 1996

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

Pfizer describes anticancer application for known antidepressant

Sep. 20, 1996

Taxotere-doxorubicin com0bination as first-line treatment of advanced breast cancer

Sep. 20, 1996

CI-958 for treatment of prostate cancer

Sep. 20, 1996

Further approval recommended for Novantrone

Sep. 20, 1996

New formulation of ciclosporin

Sep. 20, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...